EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection

Alireza Ghodsi, Elnaz Mahmoudabadi, Sara Ghahremani, Abdolreza Malek

Archives of Pediatric Infectious Diseases · 16.01.2021 · 9 (4)

DOI: 10.5812/pedinfect.109915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Pediatric Infectious Diseases, online erschienen am 16.01.2021. Verfasst von Alireza Ghodsi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Multisystem inflammatory syndrome in children (MIS-C) is an emerging condition after the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, termed COVID-19. This study aimed to describe the cardiac manifestations of children diagnosed with MIS-C. Evidence Acquisition: This narrative review was conducted by searching the PubMed, Scopus, and Google Scholar databases to review MIS-C cardiac manifestations up to September 30, 2020. The demographic features, past medical history, clinical signs and symptoms, cardiac involvement, and the type of COVID-19 diagnosis confirmation were extracted.

Results

In many children, MIS-C seems to be a post-infectious complication of the COVID-19 infection. This syndrome affects multiple organs and has various clinical manifestations mimicking Kawasaki disease. Patients frequently present with persistent fever, kidney injury, gastrointestinal (GI) problems, neurologic symptoms, mucosal changes, conjunctivitis, and cardiac involvement. Children with MIS are more likely to present with hypotension, shock, and cardiac dysfunction, rather than coronary artery abnormalities and arrhythmia. Children with MIS need close observation; some need to be hospitalized, and a few may need a Pediatric Intensive Care Unit (PICU) admission. Treatment currently includes anticoagulants, IV immunoglobulin, and anti-inflammatory drugs.

Conclusions

As a novel syndrome associated with SARS-CoV-2 infection, MIS-C is potentially lethal. Cardiac manifestations, including coronary and myocardial involvement, are common and should be carefully identified. With prompt diagnosis and proper treatment, most children will survive, but the outcomes of the disease are unknown, so long-term follow-ups are required.

Zitieren

APA

Ghodsi, A., Mahmoudabadi, E., Ghahremani, S., & Malek, A. (2021). Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection. Archives of Pediatric Infectious Diseases, 9(4). https://doi.org/10.5812/pedinfect.109915

Vancouver

Ghodsi A, Mahmoudabadi E, Ghahremani S, Malek A. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection. Archives of Pediatric Infectious Diseases. 2021;9(4). doi:10.5812/pedinfect.109915

BibTeX
@article{Ghodsi2021,
  author = {Ghodsi, Alireza and Mahmoudabadi, Elnaz and Ghahremani, Sara and Malek, Abdolreza},
  title = {Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection},
  journal = {Archives of Pediatric Infectious Diseases},
  year = {2021},
  volume = {9},
  number = {4},
  doi = {10.5812/pedinfect.109915}
}
Kostenlos starten →